There are no upcoming events at this time.

View All
View Full Calendar See All Updates

Get Email Updates

Energy and Commerce Committee

Letter

Filters
Sort Content By:
Subcommittees
Post Types
Categories

Letter to CMS on Medicare Plan Finder

12.10.2019

“It is critical that Medicare beneficiaries have the most accurate and up-to-date information and that Medicare provides them with reliable information on their health care costs and coverage information relevant to their needs,” the bipartisan members wrote to Administrator Verma.“Understanding cost-sharing obligations when selecting plans is especially critical for seniors who take prescription medications that often can have costly coinsurance, tiering, and co-payment requirements.”

CLICK HERE to read the letter.

Letter

Letter to insurers on rising price of insulin

12.06.2019

Excerpt: "Unfortunately, even though the average net price that manufacturers are receiving for many insulin products is decreasing and PBMs are working with health plans to help reduce the cost of insulin for health plans, many Americans are facing increased out-of-pocket costs for their insulin at the pharmacy counter," the leaders wrote in their letters. "We are therefore examining the role of insurers in the prescription drug supply chain, including questions about how insurers make decisions about plan design, the use of rebates in the insulin market, and the...

Letter

Letters regarding unfair and deceptive practices in the live event ticketing industry

11.21.2019

Excerpt: “Nonetheless, despite ongoing bipartisan efforts by the Committee, as well as federal agency action to better understand the current ticketing marketplace, consumers still face a host of troubling practices and trends in the ticketing industry. Many of these issues relate to a lack of transparency and fairness, which places purchasers at an unfair advantage when attempting to buy tickets in the current marketplace,” the Committee leaders wrote.

Click here to read the letter to Live Nation

Click here to read the letter to AEG

Click here to read the...

Letter

Letter to CMS on the National Provider Idenitifier

10.31.2019

“Recent press reports indicate that individuals have obtained multiple NPI numbers for the purpose of committing healthcare fraud and raise questions about CMS’ oversight of the NPI application process. For instance, in a recent federal prosecution, U.S. v. David Roy Williams, Mr. Williams obtained over 19 NPIs and used them to receive over $4 million in fraudulent healthcare payments from insurers such as Aetna, Cigna, and United Health,” wrote Walden, Burgess, and Guthrie.

Click here to read the letter.

Letter

Letter to CMS raising concerns about Navigator program

10.22.2019

Excerpt:  "We have been examining the Navigator program and its effectiveness since it was established. During this work, we have identified implementation challenges and wasteful spending of taxpayer dollars," the leaders wrote. "More recent reviews of the Navigator program have also found that the program has been an ineffective and inefficient use of limited government resources. For instance, for plan year 2017, navigators were awarded $62.5 million in grants and enrolled 81,426 individuals - which amounts to $767 per person."

Click here to read the letter.

Letter

Letter requesting follow-up hearing on maternal mortality

10.15.2019

Excerpt: "Despite massive innovation in health care and advancements in technology, over the last two decades, the number of American women who die each year from a pregnancy-related cause has increased dramatically," wrote Walden, Burgess, Guthrie, and Bucshon.

Click here to read the letter.

Letter

Letter calling for second hearing on partisan Pelosi plan

10.15.2019

Excerpt: "Given the testimony heard in the subcommittee hearing and the implications H.R. 3 could have on denying treatments and next generation cures to our constituents, this process must not be rushed," Walden and Burgess write.

Click here to read the letter.

Letter

Letter to Drug Enforcement Administration on Report Recommendations

10.11.2019

Excerpt: "As Members of the House Energy and Commerce Committee and leaders of an investigation into opioid distribution, we are following up on the status of recommendations directed to the Drug Enforcement Administration (DEA) to address concerns outlined in the December 19, 2018 report, Red Flags and Warning Signs Ignored: Opioid Distribution and Enforcement Concerns in West Virginia,"  Walden, Guthrie, and McKinley write in their letter to the DEA.

Click here to read the letter.

Letter
Letter